Impact of preoperative renal dysfunction on cardiac surgery results

Asian Cardiovascular and Thoracic Annals

Volumn 11, Issue 1, 2003, Pages 42-47

  Abramov, Dan ^a   Tamariz, Miguel ^a   Fremes, Stephen ^a   Tobe, Sheldon ^a   Christakis, George ^a   Guru, Veena ^a   Goldman, Bernard ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGE; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DATA BASE; DIALYSIS; FOLLOW UP; HEART SURGERY; HUMAN; KIDNEY DYSFUNCTION; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MITRAL VALVE REPLACEMENT; MORBIDITY; PLOTS AND CURVES; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL;

EID: 0037830084     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230301100111     Document Type: Article

References (16)

1. Rao V, Weisel RD, Buth KJ, Cohen GC, Borger MA, Shiono N, et al. Coronary artery bypass grafting in patients with non-dialysis-dependent renal insuficiency. Circulation 1997;96 (Suppl II):38-45.
2. Sutton RG. Renal considerations, dialysis, and ultrafiltration during cardiopulmonary bypass. Int Anesthesiol Clin 1996;34:165-76.
3. Lahey SJ, Borlass BC, Lavin PT, Levitsky S. Preoperative risk factors that predict hospital length of stay in coronary artery bypass patients > 60 years old. Circulation 1992; 86(Suppl II):181-5.
4. Fremes SE, Levy SL, Christakis GT, Walker SE, Iazzetta J, Mallidi HR, et al. A phase I human trial of adenosine-potassium cardioplegia. Circulation 1996;94 (Suppl II):370-5.
5. Cohen G, Feder-Elituv R, Iazetta J, Bunting P, Mallidi H, Bozinovski J, et al. Phase 2 studies of adenosine cardioplegia. Circulation 1998;98(Suppl II):225-33.
6. Normothermic versus hypothermic blood cardioplegia for coronary bypass surgery: A randomized trial in 1732 patients. The Warm Heart Investigators. Lancet 1994;343:559-63.
7. Spinler SA, Nawarskas JJ, Boyce EG, Connors JE, Charland SL, Goldfarb S. Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. Iohexol Cooperative Study Group. Ann Pharmacother 1998;32:1275-83.
8. Hanley JA, McNeil BJ. The meaning and use of area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
9. Hanley JA, McNeil BJ. A method for comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
10. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley, 1989.
11. Leurs PB, Mulder AW, Fiers HA, Hoorntje SJ. Acute renal failure after cardiovascular surgery. Current concepts in pathophysiology, prevention, and treatment. Eur Heart J 1989;10(Suppl H):38-42.
12. Berendes E, Mollhof T, Van Aken H, Schmidt C, Erren M, Deng MC, et al. Effects of dopexamine on creatinine clearance, systemic inflammation, and splachnic oxygenation in patients undergoing coronary artery bypass grafting. Anesth Analg 1997;84:950-7.
13. Gelman S. Ischemic insult, kidney viability, and renal function. Anesth Analg 1998;86:1-2.
14. Hashimoto K, Nomura K, Nakano M, Sasaki T, Kurosawa H. Pharmacological intervention for renal protection during cardiopulmonary bypass. Heart Vessels 1993;8:203-10.
15. Kainuma M, Yamada M, Miyaka T. Continuous urine oxygen tension monitoring in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 1996;10:803-8.
16. Lema G, Urzua J, Jalil R, Canessa R, Moran S, Sacco C, et al. Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function. Anesth Analg 1998;86:3-8.